Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HM Health Solutions, commonly abbreviated HMHS, was the former name of enGen, a Pittsburgh-based health technology company and wholly owned subsidiary of Highmark Health. The business provides enterprise software, automation, analytics, and operational services for health plans and their provider partners rather than developing therapeutics or running a traditional biotech pipeline. Its core offering is the Enterprise Health Solutions platform, a cloud-based health plan administration platform that supports functions such as member enrollment, claims processing, care management, and related workflows. The company also offers products such as Predictal for utilization, case, disease, and appeals management. For biotech and pharma screening purposes, this is a healthcare IT and payer-services company, not a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HM Health Solutions.